相关实验视频

Updated: Jul 2, 2025

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

Published on: February 22, 2022

MG53:心肌病的精确治疗的新主角

Qianru Zhao¹, Qingya Zhang², Xiaopeng Zhao¹

¹College of Exercise and Health, Shenyang Sport University, Shenyang 110102, Liaoning, PR China.

Biochemical pharmacology

|February 17, 2024

概括

三重53 (MG53) 在保护心脏免受心肌病 (CMs) 的保护方面表现有前途. 这篇评论探讨了MG53的MG53.

科学领域:

心脏病学心脏病学
分子生物学分子生物学
生物化学生物化学

背景情况:

心肌病 (CMs) 是一种进展性心脏病,其病因复杂,治疗方法有限.
三重素53 (MG53),也称为三方基因蛋白72 (TRIM72),是一种主要存在于心脏和骨肌肉中的蛋白质.
新兴研究表明,MG53具有与CMs相关的心脏保护性质.

研究的目的:

审查MG53在心肌保护中的机制.
阐明MG53在各种CM和人类心肌损伤诊断/预后中的作用.
评估复合人类MG53 (rhMG53) 对CMs的治疗潜力.

主要方法:

关于MG53和心肌病的研究文献综述.
分析MG53在心脏保护中的分子机制.
对心肌损伤中MG53的临床数据的评估.

主要成果:

MG53调解心脏损伤的保护通路.
MG53显示出作为心肌损伤生物标志物的潜力.
rhMG53在临床前模型中显示出治疗前景.

结论:

MG53是心肌保护的关键参与者,也是心肌病的潜在治疗标.
对MG53的进一步研究可能会导致改善CMs的诊断和治疗策略.
rhMG53的临床应用在治疗心脏病方面需要进一步研究.

关键词:

生物标志物生物标志物卡迪奥基因 (cardiokine) 是一种催情剂.心肌病是一种心肌病.MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53MG53M 有关TRIM蛋白质的蛋白质.rhMG53 的使用情况.

更多相关视频

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

相关概念视频

Heart Failure Drugs: Inotropic Agents

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...